Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells
Biomolecules · 2024
DOI: 10.3390/biom14111444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Jackie Trink und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, McMaster University, Hamilton, ON L8N 1Y3, Canada. Hauptthemen laut MEDLINE: Mesangial Cells, Glucose, alpha-Macroglobulins, Up-Regulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Diabetes Canada.
Abstract (Originalsprache)
Up to 40% of patients with diabetes mellitus will develop diabetic kidney disease (DKD), characterized pathologically by the accumulation of extracellular matrix proteins, which leads to the loss of kidney function over time. Our previous studies showed that the pan-protease inhibitor alpha 2-macroglobulin (A2M) is increased in DKD and is a critical regulator of the fibrotic response in glomerular mesangial cells (MC), an initial site of injury during DKD development. How A2M is regulated by high glucose (HG) has not yet been elucidated and is the focus of this investigation. Using serial deletions of the full A2M promoter, we identified the −405 bp region as HG-responsive in MC. Site-directed mutagenesis, siRNA, and ChIP studies showed that the transcription factor, nuclear factor of activated T cells 5 (NFAT5), regulated A2M promoter activity and protein expression in response to HG. Forkhead box P1 (FOXP1) served as a cooperative binding partner for NFAT5, required for A2M upregulation. Lastly, we showed that Smad3, known for its role in kidney fibrosis, regulated A2M promoter activity and protein production independently of HG. The importance of NFAT5, FOXP1, and Smad3 in A2M regulation was confirmed in ex vivo studies using isolated glomeruli. In conclusion, Smad3 is required for basal and HG-induced A2M expression, while NFAT5 and FOXP1 cooperatively regulate increased A2M transcription in response to HG. Inhibition of NFAT5/FOXP1 will be further evaluated as a potential therapeutic strategy to inhibit A2M production and attenuate profibrotic signaling in DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, McMaster University, Hamilton, ON L8N 1Y3, Canada.
- St. Joseph's Hospital, 50 Charlton Ave East, Rm T3311, Hamilton, ON L8N 4A6, Canada.
ORCID-Profile: Joan C Krepinsky
Förderung
- Canadian Institutes of Health Research (CIHR)
- Diabetes Canada
Zitieren
APA
Trink, J., Li, R., Gao, B., Lu, C., & Krepinsky, J. C. (2024). Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells. Biomolecules. https://doi.org/10.3390/biom14111444
Vancouver
Trink J, Li R, Gao B, Lu C, Krepinsky JC. Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells. Biomolecules. 2024. doi:10.3390/biom14111444
BibTeX
@article{Trink2024,
author = {Trink, Jackie and Li, Renzhong and Gao, Bo and Lu, Chao and Krepinsky, Joan C},
title = {Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14111444}
}
EUVIMED